This chemical is widely used in the pharmaceutical industry as a key intermediate in the synthesis of various biologically active compounds. Its boronic acid group makes it valuable in Suzuki-Miyaura cross-coupling reactions, which are essential for creating complex molecules, including potential drug candidates. It is particularly useful in the development of treatments targeting specific diseases, such as cancer or inflammatory disorders, due to its ability to form stable bonds with other organic molecules. Additionally, its trifluoromethylphenyl group enhances the compound's metabolic stability and bioavailability, making it a preferred choice in medicinal chemistry research.